OptimizeRx Corp (NAS:OPRX)

$ 6.14 -0.13 (-2.07%) Market Cap: 112.50 Mil Enterprise Value: 135.09 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 71/100

Q2 2024 OptimizeRx Corp Earnings Call Transcript
Aug 08, 2024

$8.85 (+6.88%)

Earnings
Q1 2024 OPTIMIZERx Corp Earnings Call Transcript
May 14, 2024

$10.48 (-0.57%)

Earnings
Q4 2023 OPTIMIZERx Corp Earnings Call Transcript
Mar 28, 2024

$12.15

Earnings
Q3 2023 OPTIMIZERx Corp Earnings Call Transcript
Nov 06, 2023

$9.79 (+15.31%)

Earnings
OPTIMIZERx Corp to Discuss Medicx Health Acquisition Call Transcript
Oct 12, 2023
Q2 2023 OPTIMIZERx Corp Earnings Call Transcript
Aug 14, 2023

$12.57 (-2.10%)

Earnings
OPTIMIZERx Corp at William Blair Growth Stock Conference Transcript
Jun 08, 2023
OPTIMIZERx Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Q1 2023 OPTIMIZERx Corp Earnings Call Transcript
May 10, 2023

$14.28 (-0.76%)

Earnings
Q4 2022 OPTIMIZERx Corp Earnings Call Transcript
Mar 08, 2023

$16.24 (-2.87%)

Earnings
Q3 2022 OPTIMIZERx Corp Earnings Call Transcript
Nov 08, 2022

$14.52 (-0.14%)

Earnings
Q2 2022 OPTIMIZERx Corp Earnings Call Transcript
Aug 09, 2022

$22.25 (-6.43%)

Earnings
Q1 2022 OPTIMIZERx Corp Earnings Call Transcript
May 04, 2022

$29.97 (+3.88%)

Earnings
Q4 2021 OPTIMIZERx Corp Earnings Call Transcript
Feb 24, 2022

$42.97 (+8.43%)

Earnings
OPTIMIZERx Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 OPTIMIZERx Corp Earnings Call Transcript
Nov 09, 2021

$85.84 (-8.06%)

Earnings
Q2 2021 OPTIMIZERx Corp Earnings Call Transcript
Aug 04, 2021

$57.47 (+3.03%)

Earnings
Q1 2021 OPTIMIZERx Corp Earnings Call Transcript
May 06, 2021

$47.95 (-4.39%)

Earnings
Q4 2020 OPTIMIZERx Corp Earnings Call Transcript
Feb 24, 2021

$57.53 (+3.49%)

Earnings
OPTIMIZERx Corp Annual Shareholders Meeting Transcript
Nov 19, 2020
Q3 2020 OPTIMIZERx Corp Earnings Call Transcript
Nov 09, 2020

$21.2 (-1.26%)

Earnings
Q2 2020 OPTIMIZERx Corp Earnings Call Transcript
Aug 05, 2020

$15.48 (+0.45%)

Earnings
OPTIMIZERx Corp at RBC Global Healthcare Conference (Virtual) Transcript
May 19, 2020
OPTIMIZERx Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020
Q1 2020 OPTIMIZERx Corp Earnings Call Transcript
May 04, 2020

$9.28 (-0.64%)

Earnings
OptimizeRx Corporation - Special Call Transcript
Apr 22, 2020
Q4 2019 OPTIMIZERx Corp Earnings Call Transcript
Feb 27, 2020

$10.03 (-11.16%)

Earnings
Q3 2019 OPTIMIZERx Corp Earnings Call Transcript
Nov 05, 2019

$12.04 (-4.37%)

Earnings
Q2 2019 OPTIMIZERx Corp Earnings Call Transcript
Aug 07, 2019

$13.6 (-5.29%)

Earnings
Q1 2019 OPTIMIZERx Corp Earnings Call Transcript
May 08, 2019

$11.48 (+2.50%)

Earnings
Q4 2018 OPTIMIZERx Corp Earnings Call Transcript
Feb 26, 2019

$13.52 (-2.38%)

Earnings

Q2 2023 OPTIMIZERx Corp Earnings Call Transcript

Aug 14, 2023 / 08:30PM GMT

Release Date Price: $12.57 (-2.10%)

Transcript 10-Q8-K

Operator

Good afternoon, everyone, and thank you for joining OptimizeRx' Second Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by the company's Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.

At the conclusion of today's earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today's call. I would like to remind everyone that today's call is being recorded and will be made available for replay via webcast only. Instructions are included in today's press release and in the Investors section of the company's website.

Now I would like to turn the call over to OptimizeRx CEO, William Febbo. Sir, please go ahead.

William J. Febbo

OptimizeRx Corporation - CEO & Director

Good afternoon, everyone, and thank you for joining our second quarter earnings

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.